Management Strategies in Advanced Uterine Leiomyosarcoma: Focus on Trabectedin

Table 3

Patients included in pooled analysis of five phase II studies.

Phase II studies	Reference	Evaluable patients (); Total	1st line therapy
ET-B-005	Le Cesne et al. [53]	16	No
ET-B-008	Yovine et al. [54]	7	No
ET-B-016	Garcia-Carbonero et al. [55]	6	Yes
ET-B-017	Garcia-Carbonero et al. [56]	3	No
ET743-STS-201	Demetri et al. [57]	30	No